Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H25N.ClH |
| Molecular Weight | 207.784 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)CCCC(C)NC(C)C
InChI
InChIKey=QYEORIIWGAAORG-UHFFFAOYSA-N
InChI=1S/C11H25N.ClH/c1-9(2)7-6-8-11(5)12-10(3)4;/h9-12H,6-8H2,1-5H3;1H
Approval Year
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 34.0 |
no | |||
Page: 34.0 |
no |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 36 | 38 |
no |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 19.0 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: A daily combination dosage of iproheptine hydrochloride for an adult is usually between 10 and 225 mg, preferably between 20 and 200 mg, more preferably between 30 and 150 mg. http://www.google.ch/patents/WO2005094832A1
Maximum daily dose - 150mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4013-92-7
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY | |||
|
DTXSID30960567
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY | |||
|
C97701
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY | |||
|
100000086453
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY | |||
|
VFP5V1ZZMK
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL2103925
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY | |||
|
SUB02770MIG
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY | |||
|
19916
Created by
admin on Mon Mar 31 18:49:26 GMT 2025 , Edited by admin on Mon Mar 31 18:49:26 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD